<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en"><title>News on Sanofi-Aventis Sa</title><link href="http://obesityintheus.com/topic/sanofi-aventis-sa" rel="alternate"></link><id>http://obesityintheus.com/topic/sanofi-aventis-sa</id><updated>2010-10-21T09:46:36Z</updated><entry><title>One in three Britons forecast to be obese by 2012</title><link href="http://obesityintheus.com/britons-forecast-obese-2012-2314620a" rel="alternate"></link><updated>2010-10-21T09:46:36Z</updated><author><name>Forbes</name></author><id>tag:obesityintheus.com,2010-10-21:/britons-forecast-obese-2012-2314620a/</id><summary type="html">...</summary><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Type 2 Diabetes"></category><category term="Obesity"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Europe"></category><category term="Community Health Corporation"></category><category term="University College London"></category><category term="Western Europe"></category><category term="Sanofi-Aventis SA"></category><category term="Acomplia"></category><category term="England"></category><category term="Body Weight"></category><category term="Paola Zaninotto"></category></entry><entry><title>Sanofi-Aventis ends research on troubled diet drug</title><link href="http://obesityintheus.com/sanofiaventis-ends-research-troubled-diet-drug-337290a" rel="alternate"></link><updated>2010-06-11T22:26:48Z</updated><author><name>AP News</name></author><id>tag:obesityintheus.com,2010-06-11:/sanofiaventis-ends-research-troubled-diet-drug-337290a/</id><summary type="html">&lt;div id="subtitle"&gt;&lt;a title="Sanofi-Aventis SA" href="/topic/Sanofi-Aventis+SA" &gt;Sanofi-Aventis&lt;/a&gt; ends research on troubled diet drug, 2 weeks after halting sales in &lt;a title="Europe" href="/topic/Europe" &gt;Europe&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;p&gt;French drugmaker Sanofi-Aventis is halting all research on a once-promising diet drug that never made it to the U.S. market.&lt;/p&gt;&lt;p&gt;The &lt;a title="Paris" href="/topic/Paris" &gt;Paris&lt;/a&gt;-based company, in the world's No. 4 drugmaker, said Wednesday that it is stopping all...</summary><category term="Politics"></category><category term="Political Policy"></category><category term="Domestic Policy"></category><category term="Social Policy"></category><category term="Public Health Policy"></category><category term="Obesity"></category><category term="United States"></category><category term="European Union"></category><category term="Europe"></category><category term="European Commission"></category><category term="Food and Drug Administration"></category><category term="European Medicines Agency"></category><category term="Sanofi-Aventis SA"></category><category term="Acomplia"></category><category term="Body Weight"></category></entry><entry><title>Sanofi-Aventis suspends Acomplia sales in Europe</title><link href="http://obesityintheus.com/sanofiaventis-suspends-acomplia-sales-europe-219890a" rel="alternate"></link><updated>2010-04-16T16:22:11Z</updated><author><name>AP News</name></author><id>tag:obesityintheus.com,2010-04-16:/sanofiaventis-suspends-acomplia-sales-europe-219890a/</id><summary type="html">&lt;p&gt;&lt;div id="subtitle"&gt;&lt;a title="Sanofi-Aventis SA" href="/topic/Sanofi-Aventis+SA" &gt;Sanofi-Aventis&lt;/a&gt; suspends sales of anti-obesity drug &lt;a title="Acomplia" href="/topic/Acomplia" &gt;Acomplia&lt;/a&gt; in &lt;a title="Europe" href="/topic/Europe" &gt;Europe&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;p&gt;French pharmaceutical company Sanofi-Aventis temporarily suspended sales of anti-obesity drug Acomplia in Europe, the company said Thursday, after health authorities said the drug's risks outweigh its benefits.&lt;/p&gt;&lt;p&gt;Sanofi-Aventis will ...</summary><category term="Mental Health"></category><category term="Obesity"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="European Union"></category><category term="United Kingdom"></category><category term="Europe"></category><category term="Food and Drug Administration"></category><category term="France"></category><category term="European Medicines Agency"></category><category term="Western Europe"></category><category term="Sanofi-Aventis SA"></category><category term="Acomplia"></category><category term="Gerard Le Fur"></category><category term="Paris (France)"></category><category term="London (England)"></category></entry><entry><title>Sanofi's U.S. Ambitions Dragged By Drug</title><link href="http://obesityintheus.com/sanofis-ambitions-dragged-drug-2293108a" rel="alternate"></link><updated>2010-10-21T09:34:48Z</updated><author><name>Forbes</name></author><id>tag:obesityintheus.com,2010-10-21:/sanofis-ambitions-dragged-drug-2293108a/</id><summary type="html">...</summary><category term="Obesity"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="United Kingdom"></category><category term="Europe"></category><category term="France"></category><category term="Western Europe"></category><category term="Sanofi-Aventis SA"></category><category term="Forbes Media LLC"></category><category term="ABN AMRO Holding NV"></category><category term="Acomplia"></category><category term="England"></category><category term="Paris (France)"></category><category term="London (England)"></category><category term="Michael Leacock"></category><category term="Body Weight"></category></entry><entry><title>Rimonabant is a Unique Drug to Get Rid of Obesity Quickly</title><link href="http://obesityintheus.com/rimonabant-unique-drug-rid-obesity-quickly-1313179a" rel="alternate"></link><updated>2010-09-10T14:26:52Z</updated><author><name>ArticlesBase</name></author><id>tag:obesityintheus.com,2010-09-10:/rimonabant-unique-drug-rid-obesity-quickly-1313179a/</id><summary type="html">&lt;p&gt;We are living in an advanced world, which has changed its life style completely, and with change in life style many new complications have taken birth. Obesity is a disease, which has its lineage with modern life style. We are sustaining our lives in a hectic schedule where we don't have time to pay proper attention to our body. Even when people caught in diseases like cold, fever etc. they hardly get time to take an appointment with the doctor. Obesity and problems related with it do not aff...</summary><category term="Diet and Nutrition"></category><category term="Obesity"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Union"></category><category term="Iceland"></category><category term="Norway"></category><category term="Germany"></category><category term="United Kingdom"></category><category term="Europe"></category><category term="Food and Drug Administration"></category><category term="France"></category><category term="Western Europe"></category><category term="Sanofi-Aventis SA"></category><category term="Nordic Countries"></category><category term="Acomplia"></category><category term="Rimonabant"></category><category term="Body Weight"></category></entry><entry><title>Buy Acomplia Rimonabant and Live Life Like a King</title><link href="http://obesityintheus.com/buy-acomplia-rimonabant-live-life-king-1137146a" rel="alternate"></link><updated>2010-09-09T10:18:11Z</updated><author><name>ArticlesBase</name></author><id>tag:obesityintheus.com,2010-09-09:/buy-acomplia-rimonabant-live-life-king-1137146a/</id><summary type="html">&lt;p&gt;Good health is a blessing which is more valuable than millions of dollars. Once health starts deteriorating even a millionaire can become a beggar. Planned and proper life style ipso-facto keeps away from many diseases. Improper and unplanned life style is an invitation for many dangerous diseases like obesity to come into your life. Calling obesity and diseases related with it "a herd of life snatching beasts" is not an exaggeration. Fatal diseases like cardio-vascular trouble, arthritis, br...</summary><category term="Obesity"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Denmark"></category><category term="Germany"></category><category term="United Kingdom"></category><category term="Europe"></category><category term="Food and Drug Administration"></category><category term="Western Europe"></category><category term="Sanofi-Aventis SA"></category><category term="Nordic Countries"></category><category term="Acomplia"></category><category term="Rimonabant"></category><category term="Body Weight"></category></entry></feed>
